Peginterferon alfa-2a Pegasys - Treatment - Hepatitis C Online

Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C - William Kemp, Stuart Roberts, 2011

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses - ScienceDirect

Cost-effectiveness of peginterferon alfa-2a (40 kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection - ScienceDirect

Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial

Pegasys Medicare Coverage and Co-Pay Details - GoodRx

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

Peginterferon alfa-2a plus ribavirin for treating chronic hepatitis C virus infection: Analysis of Mexican patients included in a multicenter international clinical trial

Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial - The Lancet Gastroenterology & Hepatology

Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response - Gastroenterology

Treatment - Hepatitis C Online

Using Pegylated Interferon and Ribavirin to Treat Patients with Chronic Hepatitis C